Computational methods for modeling protein–protein interactions in the AI era: Current status and future directions

IF 6.5 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Hao Li , Chandran Nithin , Sebastian Kmiecik , Sheng-You Huang
{"title":"Computational methods for modeling protein–protein interactions in the AI era: Current status and future directions","authors":"Hao Li ,&nbsp;Chandran Nithin ,&nbsp;Sebastian Kmiecik ,&nbsp;Sheng-You Huang","doi":"10.1016/j.drudis.2025.104382","DOIUrl":null,"url":null,"abstract":"<div><div>The modeling of protein–protein interactions (PPIs) has been revolutionized by artificial intelligence, with deep learning and end-to-end frameworks such as AlphaFold and its derivatives now dominating the field. This review surveys the current computational landscape for predicting protein complex structures, outlining the role of traditional docking approaches as well as focusing on recent advances in AI-driven methods. We discuss key challenges, including protein flexibility, reliance on co-evolutionary signals, modeling of large assemblies, and interactions involving intrinsically disordered regions (IDRs). Recent innovations aimed at improving sampling diversity, integrating experimental data, and enhancing robustness are also highlighted. Although classical methods remain relevant in specific contexts, the continued evolution of AI-based tools offers transformative potential for structural biology. These advances are poised to deepen our understanding of biomolecular interactions and accelerate the design of therapeutic interventions.</div></div>","PeriodicalId":301,"journal":{"name":"Drug Discovery Today","volume":"30 6","pages":"Article 104382"},"PeriodicalIF":6.5000,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Discovery Today","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1359644625000959","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

The modeling of protein–protein interactions (PPIs) has been revolutionized by artificial intelligence, with deep learning and end-to-end frameworks such as AlphaFold and its derivatives now dominating the field. This review surveys the current computational landscape for predicting protein complex structures, outlining the role of traditional docking approaches as well as focusing on recent advances in AI-driven methods. We discuss key challenges, including protein flexibility, reliance on co-evolutionary signals, modeling of large assemblies, and interactions involving intrinsically disordered regions (IDRs). Recent innovations aimed at improving sampling diversity, integrating experimental data, and enhancing robustness are also highlighted. Although classical methods remain relevant in specific contexts, the continued evolution of AI-based tools offers transformative potential for structural biology. These advances are poised to deepen our understanding of biomolecular interactions and accelerate the design of therapeutic interventions.
人工智能时代蛋白质-蛋白质相互作用建模的计算方法:现状与未来方向
人工智能已经彻底改变了蛋白质-蛋白质相互作用(ppi)的建模,深度学习和端到端框架(如AlphaFold及其衍生产品)现在主导了该领域。本文综述了目前预测蛋白质复合物结构的计算前景,概述了传统对接方法的作用,并重点介绍了人工智能驱动方法的最新进展。我们讨论了关键的挑战,包括蛋白质的灵活性,对共同进化信号的依赖,大组装的建模,以及涉及内在无序区域(IDRs)的相互作用。最近的创新旨在提高采样多样性,整合实验数据,增强鲁棒性也突出。尽管经典方法在特定情况下仍然相关,但基于人工智能的工具的持续进化为结构生物学提供了变革的潜力。这些进展将加深我们对生物分子相互作用的理解,并加速治疗干预措施的设计。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug Discovery Today
Drug Discovery Today 医学-药学
CiteScore
14.80
自引率
2.70%
发文量
293
审稿时长
6 months
期刊介绍: Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed. Features include comment by international experts, news and analysis of important developments, reviews of key scientific and strategic issues, overviews of recent progress in specific therapeutic areas and conference reports.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信